SLC2A5 and cancer: Overexpression of SLC2A5 enhances LUAD cellproliferation, migration, invasion, and tumorigenicity in fructose-containing culturemedium, and cancer cells are more sensitive to paclitaxel treatment after inhibition ofGLUT5 with 2,5-AM.